TLRY
Tilray Brands, Inc. Common Stock
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Best Pharmaceutical Stocks 2026 →
Tilray Brands (TLRY) Stock: Buy, Sell, or Hold?
$2.49
-0.12 (-4.60%)
▼
5d:
-11.39%
30d:
-20.7%
90d:
-46.68%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 08, 2026
0d
Protect TLRY Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (57%)
Quality Score
54/100
Position
OVERSOLD
30-Day Fair Range
$2.62 – $3.37
Position: OVERSOLD
Forward P/E & Valuation
-6.7x
CHEAP
vs 201.6x historical avg
Wall Street Target
$5.72
+119.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.47 / $3.00
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: TLRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 2, 2026 at $2.52 · last confirmed Nov 11, 2026
Strength: 8.9/10
Get Alerted When TLRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TLRY is currently trading at $2.49, which is considered oversold relative to its 30-day fair value range of $2.62 to $3.37. From a valuation perspective, the stock is trading at a discount (Forward PE: -6.7) compared to its historical average (201.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TLRY is in a strong uptrend. The price is currently testing key support at $2.47. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: TLRY scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.72 (+119.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TLRY is in a strong uptrend. The price is currently testing key support at $2.47. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: TLRY scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.72 (+119.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.62 -
$3.37
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Trading Range & Key Levels
30-Day Trading Range
$2.62 -
$3.37
Current vs Trading Range
OVERSOLD
Support Level
$2.47
Resistance Level
$3.00
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding TLRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 119.2% below Wall St target ($5.72)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: 5-day price weakness (-11.4%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-6.67
Wall Street Target
$5.72
(+119.2%)
Revenue Growth (YoY)
22.7%
Profit Margin
-17.1%
PE vs Historical
-6.7 vs 201.6
CHEAP
Share TLRY Analysis
Share this live TLRY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TLRY)
Bearish
10 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
9 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
The social media sentiment towards $TLRY is predominantly bearish, with critics targeting the company's leadership and financial performance. No recent news articles were identified.
Key Retail Themes:
Leadership and management
Financial performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 4:02 PM ET
Data refreshes hourly during market hours. Next update: 5:02 PM
Data refreshes hourly during market hours. Next update: 5:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Advanced TLRY Option Strategies
Professional options setups generated by AI based on today's TLRY price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TLRY Research Pages
